Abstract
Radiohalogenated compounds have been used in biomedical research and diagnostic nuclear medicine for many years. In the past ten years, interest in the development and use of radiohalogenated compounds has increased significantly, particularly for 123I,75Br, and 18F labeled compounds for imaging; 125I labeled compounds for autoradiography; as well as 131I, 125I, and 80mBr for radiotherapeutic applications. The radiohalogenation of compounds for these applications poses special synthetic constraints. In many cases, the radiohalogen must be incorporated at a specific position in the molecule in order to retain biological activity, and at a position which is metabolically stable towards dehalogenation. For radioiodinated and radiobrominated compounds, this often dictates that the radiotracer be an aryl-or vinylradiohalide. It is also important that these radiolabeled compounds be prepared in short reaction times, in high radiochemical yields, and at high specific activity. While high specific activity is generally desirable to reduce unwanted pharmacological or physiological side effects, high specific activity (on the order of 1,000 Ci/mmol) is required for receptor studies to prevent saturation of the receptor by carrier.
Chapter PDF
References
Seevers, R.H.; Counsel, R.E.; Chem. Rev. 1982, 82, 575.
Kabalka, G W; Vanna, R.S.: Tetrahedron 1989, 45 (21), 6601.
Lever, J.R.; Datum’s, R.F.; Wilson, A.A.; Raven, H.T.; Wagner, Jr., H.N.: Tetrahedron Lett. 1987, 28, 4015.
Ku, H.; Barrio, J.R.: J. Org. Chem. 1981, 46 (25), 5239.
Chan, T.H.; Fleming, I.: Synthesis 1979, 761.
Habich, D.; Effenberger F.: Synthesis 1979, 841.
Negishi, E.: Organometallics in Organic Synthesis; John Wiley and Sons: New York, 1980; Vol. 1, p. 403.
Earbom, C; Pande, K.C.: J. Chem. Soc. 1960, 1566.
Pray, B.O.; Sommer, L.H.; Goldberg, G.M.; Ken, G.T.; DiGiorgio, P.A.; Whitmore, F.C.: J. Am. Chem. Soc. 1948, 70, 433.
Felix, G; Dunogues, J.; Pisciotti, F.; Calas R.: Angew. Chem. Int. Ed. Engl. 1977, 16, 488.
Felix, G.; Dunogues, J.; Calas, R.: Angew. Chem. Int. Ed. Engl. 1979, 18, 402.
Wilbur, D.S.; Anderson, K.W.; Stone, W.E.; O’Brien, Jr., H.A.l J. Label. Comp. and Radiopharm. 1982, XIX (10), 1171.
Wilbur, D.S.; Stone, W.E.; Anderson, K.W.L J. Org. Chem. 1983, 48, 1542.
Wilson, S.R.; Jacob, L.A.L J. Org. Chem. 1986, 51 (25), 4833.
Moerlein, S.M.; Coenen, H.H.: J. Chem. Soc., Perkin Trans. 1 1985, 1941.
Moerlein, S.M.; Beyer, W.; Stocklin, G. J.: Chem. Soc., Perkin Trans. 1 1988, 779.
Moerlein, S.M.: J. Chem. Soc., Perkin Trans. 1 1985, 1687.
Wilbur, D.S.; Svitra, Z.V.: J. Label. Comp. and Radiopharm. 1983, XX (5), 619.
Wilson, A.A.; Dannals, R.F.; Ravert, H.T.; Bums, H.D.; Wagner, Jr., H.N.; J. Label. Comp. and Radiopharm. 1985, XXIII (1), 83.
Wilson, A.A.; Dannals, R.F.; Ravert, H.T.; Frost, J.J.; Wagner, Jr., H.N.: J. Med. Chem. 1989, 32, 1057.
Bums, H.D.; Eng, W.-s.; Gibson, R.E.; Ransom, R.W.; Thorpe, H.; Fioravanti, C.; Magill, C.A.; Solomon, H.F.: J. Nucl. Med. 1989, 30 (5), 923.
Ransom, R.W.; Eng, W.-s.; Bums, H.D.; Gibson, R.E.; Solomon, H.F.: Life Sci. 1990, 46, 1103.
Wilson, A.A.; Scheffel, U.; Stathis, M.; Dannals, R.F.; Ravers, H.T.; Wagner, Jr., H.N.: J. Nucl. Med. 1990, 31 (5), 797.
Ohmomo, Y.; Okuyama, S.; Magata, Y.; Ueno, Y.; Tanaka, C.; Yokoyama, A.: Chem. Pharm. Bull. 1989, 37 (9), 2276.
Wilbur, D.S.; Svitra, Z.V.: J. Label. Comp. and Radiopharm. 1984, XXI (5), 415.
Kilbourn, M.R.: Fluorine-18 Labeling of Radiopharmaceuticals National Academy Press: Washington DC, 1990; p 32.
Adam, M.J.; Berry, J.M.; Hall, L.D.; Pate, B.D.; Ruth, T.J.: Can. J. Chem. 1983, 61, 658.
DiRaddo, P.; Diksic, M.; Jolly, D.: J. Chem. Soc., Chem. Commun. 1984, 159.
Speranza, M.; Shiue, C.; Wolf, A.P.; Wilbur, D.S.; Angelini, G.: J. Chem. Soc.., Chem. Commun. 1984, 1448.
Speranza, M.; Shiue, C.-Y.; Wolf, A.P.; Wilbur, D.S.; Angelini, G.: J. Fluorine Chem. 1985, 30, 97.
Coenen, H.H.; Moerlein, S.M.: J. Fluorine Chem. 1987, 36, 63.
Diksic, M.; Farrokhzad, S.: J. Nucl. Med. 1985, 26, 1314.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Burns, H.D., Eng, Ws., Brenner, N.J., Francis, B.E. (1991). Application of Organosilicon Chemistry to the Synthesis of Gamma and Positron Emitting Radiotracers for Use in Nuclear Imaging Studies. In: Emran, A.M. (eds) New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0626-7_25
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0626-7_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0628-1
Online ISBN: 978-1-4899-0626-7
eBook Packages: Springer Book Archive